Vancouver, British Columbia — December 17, 2025 — Leads & Copy — Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) has appointed Gail Edgell to its Advisory Board.
Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement, and education-based commercialization, contributing to consistent revenue growth across several companies.
Stephen Davis, CEO of Frequency Exchange Corp., stated that Edgell brings a deep understanding of the wellness practitioner ecosystem and how to build lasting commercial and educational relationships in that space. He added that her insights will support their efforts to scale NIKKI’s reach into professional, consumer, and community-based health channels.
Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5 million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1 million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech startup, and has advised numerous integrative health clinics on operational growth and patient education strategies.
Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former nonprofit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and healthcare educators to reimagine practitioner support experiences.
Frequency Exchange Corp. (TSXV: FREQ; OTC: FRECF) is the parent company of FREmedica Technologies Inc., a developer and commercializer of frequency-based digital wellness technologies. The Company’s flagship product, NIKKI, delivers programmable frequency wellness programs designed to support cellular communication and overall wellbeing.
Originally developed to support those with Lyme disease, the NIKKI platform has evolved to address broader use cases, including sleep, pain, energy, immune support, and athletic recovery. The Company’s technology is supported by ongoing testing and quality-of-life evaluations.
For more information, please contact:
Frequency Exchange Corp. FREmedica Technologies Inc.
Stephen Davis Nicole Sullivan
CEO & Director President
250-732-7170 Nicole.sullivan@wearenikki.com
Source: Frequency Exchange Corp.
